Telehealth is a new frontier for pharmacists, Leal says
Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »
Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »
An increasing number of groups are voicing their opposition to proposals by the Trump administration to force drug companies and medical device manufacturers to source materials in the United States, according to one trade organization. Read More »
Kaiser Permanente to join as a governing member with the goal of helping to secure supplies of essential generic medications during COVID-19 and beyond Read More »
Pharmacy Times, the leading publication for pharmacists in the nation, in an independent survey conducted with U.S. News & World Report has again named Prevagen the #1 pharmacist recommended memory support brand. Read More »
Nature Made® is once again the leading choice of pharmacists in nine key vitamin and supplement segments, according to a broad survey and ranking of top recommended health products released by U.S. News & World Report, in collaboration with Pharmacy Times. Nature Made is ranked as the #1 Pharmacist Recommended brand for:1 Read More »
A pharmacy benefit manager believes that even though Big Pharma doesn't have a great reputation and is generally distrusted, these companies have stepped up their game in the wake of COVID-19 when it comes to development and research to help patients, Yahoo! Finance reports. Read More »
Sourcing activity for pharmaceutical contract manufacturing has gone up 234% since last year and 220% since last quarter, ThomasNet reported. Read More »
The Centers for Disease Control and Prevention has updated its guidance on providing non-COVID-19 clinical care during the pandemic. Read More »
A new report captures the progress and potential of immunotherapy to fight cancer a decade after the first treatment was approved by the U.S. Food and Drug Administration. Read More »
Gojji, a data-driven chronic care management company, has partnered with PerformRx, a URAC and NCQA-accredited full-service pharmacy benefit manager (PBM), to provide state- of-the-art chronic disease management products and best in class clinical services for their clients. Read More »
American Regent announces the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to Delestrogen®1,2. Read More »
Holograms could be a key tool in fighting fake pharmaceuticals, according to a story in European Pharmaceutical Manufacturer. Read More »
PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCK™ (ripretinib). Read More »
New medicine one of several limited distribution drugs available through specialty pharmacy Read More »
Leading provider of natural wellness solutions, Innovative Pharmaceutical Solutions Group, expresses concern over the activities of online platforms against companies selling PPE items Read More »
Orsini Pharmaceutical Services is a select dispensing pharmacy for the first FDA-approved, infused migraine preventive therapy by pharmaceutical manufacturer H. Lundbeck A/S based in Denmark Read More »
In a digital ad campaign, the advocacy group 5G Action Now highlights five facts about 5G technology's vital role in the U.S. healthcare system and the fight against COVID-19. Read More »
The American Pharmacists Association (APhA) cautions pharmacists and the public to be wary of fraudulent COVID-19 products and scams being offered online or through other channels during the pandemic. Read More »
The Synthetic Biology Leader Steps Out to Help Fight COVID-19 Read More »
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women's Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA, Associate Professor of Anesthesia and co-director of the Center for Perioperative Research at Brigham and Women's Hospital and Harvard Medical School. Read More »